Understanding Information Preferences, Risk Perceptions, and Tradeoffs When Making Decisions About Multi-cancer Early Detection Tests

Conditions

• Early Detection of Cancer

Eligibility Criteria

Sex

ALL

Age

40 Years - 74 Years

Healthy Volunteers

Not accepted

Interventions

• Test Performance Information: High Detail — BEHAVIORAL
  The test performance data presented in the vignette will focus on established evidentiary standards for the evaluation of screening tests: Sensitivity, specificity, positive and negative predictive values, and the ability of tests to find specific cancers and more early-stage cancers. The high numerical detail condition will utilize these numbers and present them according to the decision aid criteria for presenting treatment option data and addressing health literacy.
• Test Performance Information: Low Detail — BEHAVIORAL
  The low numerical detail condition will describe the potential for false positives and use descriptions to denote qualitatively performance (high, acceptable, moderate, low). The test performance data presented in the vignette will focus on established evidentiary standards for the evaluation of screening tests: Sensitivity, specificity, positive and negative predictive values, and the ability of tests to find specific cancers and more early-stage cancers.
• Diagnostic Workup Information: High Detail — BEHAVIORAL
  The high numerical data will use diagnostic workup data from the most up-to-date findings at the time of survey fielding. Data will be presented on the number of positive tests, follow up included (type and properties of tests), likelihood of receiving each type of test upon a positive findings, and data on median length of time to diagnostic resolution for both true positives and false positives.
• Diagnostic Workup Information: Low Detail — BEHAVIORAL
  The low numerical detail condition will describe the possibility of further testing (more blood tests, imaging, and/or procedures) that may be required if the multi-cancer early detection (MCED) test has a positive finding, in line with prior studies communicating about MCED test workup.
• Test and Workup Cost Information: High Detail — BEHAVIORAL
  Cost estimates will include insurance and out of pocket costs associated with various pathways of diagnostic workup. The investigators will use test cost estimates based on market rates and insurance coverage mandates at the time of fielding the survey. The high numerical data condition will provide precise estimates conditioned on level of workup and insurance coverage. As above, the final content will be informed by new information that may be gleaned from ongoing studies.
• Test and Workup Cost Information: Low Detail — BEHAVIORAL
  The low numerical data will provide broad ranges of diagnostic costs, indicating what costs are covered by insurance, and which are not.

Study Details

The goal of this clinical trial is to learn what people's informational preferences and risk perceptions are in regards to the use of multi-cancer early detection (MCED) tests. Participants will be asked to review three informational factors about MCED tests and complete a survey about their intentions to use an MCED test. Some participants will also be asked to complete an interview.

Key Dates

First listed

Aug 28, 2026

Start date

Sep 30, 2027

Status verified

Aug 2026

Primary completion

Jul 31, 2028

Completion

Jul 31, 2029

Study Design

Enrollment

3,000 participants (estimated)

Allocation

RANDOMIZED

Intervention model

FACTORIAL

Primary purpose

HEALTH_SERVICES_RESEARCH

Arms

• Experimental: Arm 1: High, High, High
• Experimental: Arm 2: High, High, Low
• Experimental: Arm 3: High, Low, Low
• Experimental: Arm 4: High, Low, High
• Experimental: Arm 5: Low, High, High
• Experimental: Arm 6: Low, Low, High
• Experimental: Arm 7: Low, High, Low
• Experimental: Arm 8: Low, Low, Low

Primary Outcome Measure

Decisional Conflict [ Time Frame: 24 hours ]

Central Contacts

• Christine M Gunn, PhD
  603-646-5430
  [email protected]

Locations (1)

Find similar trials in Lebanon, NH

Related Studies

• Caris Biorepository Research Protocol
  Recruiting · Caris Science, Inc. · Mobile, Alabama
• Strategic Targeting for Optimal Prevention of Cancer
  Recruiting · ClinLogic LLC · Prosper, Texas
• Avera Cancer Sequencing and Analytics Protocol (ASAP)
  Recruiting · Avera McKennan Hospital & University Health Center · Marshall, Minnesota
• Integrating Telehealth to Advance Lung Cancer Screening
  Recruiting · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania